Try our beta test site
91 studies found for:    VARIVAX
Show Display Options
Rank Status Study
1 Completed
Has Results
Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)
Condition: Varicella
Interventions: Biological: Varicella Virus Vaccine Live (2007 Process) (Oka/Merck);   Biological: Comparator: Varicella Virus Vaccine Live (1999 Process) (Oka/Merck);   Biological: Measles, Mumps, and Rubella Virus Vaccine Live (MMR)
2 Completed
Has Results
Re-examination Study For Varivax (V210-059 AM2)
Condition: Varicella
Intervention: Biological: VARIVAX™
3 Terminated Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
Condition: Kidney Transplant Recipients
Intervention: Biological: Varivax®
4 Not yet recruiting Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Condition: Persistence of Varicella Immunity
Intervention: Biological: Varicella vaccine
5 Completed Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)
Condition: Varicella
Intervention: Biological: Varicella Virus Vaccine Live (Oka-Merck)
6 Completed
Has Results
Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)
Condition: Varicella
Interventions: Biological: VARIVAX™ New Seed Process;   Biological: VARIVAX™ 2007 process;   Biological: M-M-R II™
7 Withdrawn A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)
Condition: Varicella
Interventions: Biological: VARIVAX™ VEP;   Biological: VARIVAX™ 2007 Process;   Biological: M-M-R™ II
8 Completed
Has Results
A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)
Conditions: Varicella;   Herpes Zoster
9 Enrolling by invitation The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination
Condition: Varicella
Intervention: Biological: varicella vaccine
10 Completed
Has Results
Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years
Conditions: Tetanus;   Acellular Pertussis;   Diphtheria
Interventions: Biological: GSK Biologicals'Kinrix®;   Biological: Merck and Company's MMRII;   Biological: Merck and Company's Varivax
11 Unknown  The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation
Conditions: Organ Transplantation;   Immunosuppression
Intervention: Biological: varicella vaccine (VARIVAX)
12 Completed
Has Results
ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live;   Biological: Comparator: Placebo;   Biological: Comparator: Varivax;   Biological: Comparator: M-M-R II
13 Completed Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route
Conditions: Measles;   Mumps;   Varicella
Intervention: Biological: M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®
14 Completed Safety Study of a Refrigerator-stable Formulation of VARIVAX®
Conditions: Varicella;   Measles;   Mumps;   Rubella
Interventions: Biological: VARIVAX®;   Biological: M-M-RTM II
15 Completed Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
Condition: Chickenpox
Intervention: Biological: Live Attenuated Varicella Vaccine
16 Active, not recruiting Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children
Condition: Chickenpox
Intervention: Biological: Live Attenuated Varicella Vaccine
17 Completed A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
Condition: HIV Infections
Intervention: Biological: Varicella Virus Vaccine (Live)
18 Terminated
Has Results
A Study of ProQuad™ in Healthy Children in Korea (V221-023)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™);   Biological: M-M-R™ II and Varivax™
19 Completed Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
Conditions: Japanese Encephalitis;   Chickenpox
Interventions: Biological: Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine;   Biological: Live Attenuated Varicella Vaccine;   Biological: live attenuated JE vaccine
20 Completed Safety of a Second Dose of Biken's Varicella Vaccine
Condition: Varicella
Intervention: Biological: Live Attenuated Varicella Virus Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.